News
Biotech company Alnylam Pharmaceuticals conceded defeat for now in a lawsuit against Pfizer and BioNTech over technology in ...
The European Court of Justice Wednesday ruled there was no plausible reason to block the New York Times from getting European ...
1d
MedPage Today on MSNPfizer Confirms: Leading JAK Inhibitor Often Comes With Weight GainAfter 6 months, placebo was associated with a mean weight gain of 0.4 kg (o.88 lb), compared with 1.2-1.9 kg (2.6-4.2 lb) ...
Drugmakers' shares fell globally after President Trump said he would [sign an executive order]( ...
Income investors have liked Pfizer (NYSE: PFE) for years. However, the big drugmaker's exceptionally juicy dividend these ...
Investing.com -- Moody’s Ratings has assigned an A2 rating to Pfizer Netherlands International Finance B.V. (PNIF BV), a ...
Explore more
European Commission President Ursula von der Leyen lost a court fight against attempts to force her to disclose secret text ...
Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...
The EU’s general court has dismissed the European Commission’s refusal to disclose text messages its president Ursula von der ...
5d
24/7 Wall St. on MSNPfizer (NYSE:PFE) Hasn't Been This Cheap in 13 Years. Time to Buy?Pfizer (NYSE:PFE) is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the ...
The EU Court found the head of the European Commission, Ursula von der Leyen, responsible for concealing information about ...
European Commission President Ursula von der Leyen has lost a lawsuit attempting to force her to disclose text messages with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results